BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 11721959)

  • 1. RUNX1/AML1: a central player in hematopoiesis.
    Okuda T; Nishimura M; Nakao M; Fujita Y
    Int J Hematol; 2001 Oct; 74(3):252-7. PubMed ID: 11721959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the AML1 transcription factor in leukemogenesis.
    Lorsbach RB; Downing JR
    Int J Hematol; 2001 Oct; 74(3):258-65. PubMed ID: 11721960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transcriptionally active form of AML1 is required for hematopoietic rescue of the AML1-deficient embryonic para-aortic splanchnopleural (P-Sp) region.
    Goyama S; Yamaguchi Y; Imai Y; Kawazu M; Nakagawa M; Asai T; Kumano K; Mitani K; Ogawa S; Chiba S; Kurokawa M; Hirai H
    Blood; 2004 Dec; 104(12):3558-64. PubMed ID: 15271791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AML1 transcription factor functions to develop and maintain hematogenic precursor cells in the embryonic aorta-gonad-mesonephros region.
    Mukouyama Y; Chiba N; Hara T; Okada H; Ito Y; Kanamaru R; Miyajima A; Satake M; Watanabe T
    Dev Biol; 2000 Apr; 220(1):27-36. PubMed ID: 10720428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis.
    Kalev-Zylinska ML; Horsfield JA; Flores MV; Postlethwait JH; Vitas MR; Baas AM; Crosier PS; Crosier KE
    Development; 2002 Apr; 129(8):2015-30. PubMed ID: 11934867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Runx1/AML-1 ranks as a master regulator of adult hematopoiesis.
    Ichikawa M; Asai T; Chiba S; Kurokawa M; Ogawa S
    Cell Cycle; 2004 Jun; 3(6):722-4. PubMed ID: 15213471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core-binding factor: a central player in hematopoiesis and leukemia.
    Speck NA; Stacy T; Wang Q; North T; Gu TL; Miller J; Binder M; Marín-Padilla M
    Cancer Res; 1999 Apr; 59(7 Suppl):1789s-1793s. PubMed ID: 10197598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis.
    Okuda T; van Deursen J; Hiebert SW; Grosveld G; Downing JR
    Cell; 1996 Jan; 84(2):321-30. PubMed ID: 8565077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inability of RUNX1/AML1 to breach AML1-ETO block of embryonic stem cell definitive hematopoiesis.
    Peterson LF; Lo MC; Okumura AJ; Zhang DE
    Blood Cells Mol Dis; 2007; 39(3):321-8. PubMed ID: 17692541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of AML1/Runx1 in the pathogenesis of hematological malignancies.
    Kurokawa M; Hirai H
    Cancer Sci; 2003 Oct; 94(10):841-6. PubMed ID: 14556655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an alternatively spliced form of the mouse AML1/RUNX1 gene transcript AML1c and its expression in early hematopoietic development.
    Fujita Y; Nishimura M; Taniwaki M; Abe T; Okuda T
    Biochem Biophys Res Commun; 2001 Mar; 281(5):1248-55. PubMed ID: 11243869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The homeodomain protein Meis1 is essential for definitive hematopoiesis and vascular patterning in the mouse embryo.
    Azcoitia V; Aracil M; Martínez-A C; Torres M
    Dev Biol; 2005 Apr; 280(2):307-20. PubMed ID: 15882575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AML1 interconnected pathways of leukemogenesis.
    Michaud J; Scott HS; Escher R
    Cancer Invest; 2003; 21(1):105-36. PubMed ID: 12643014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Runx1 is essential for hematopoietic commitment at the hemangioblast stage of development in vitro.
    Lacaud G; Gore L; Kennedy M; Kouskoff V; Kingsley P; Hogan C; Carlsson L; Speck N; Palis J; Keller G
    Blood; 2002 Jul; 100(2):458-66. PubMed ID: 12091336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of a Runt domain transcription factor AML1/RUNX1 in leukemogenesis and its clinical implications.
    Asou N
    Crit Rev Oncol Hematol; 2003 Feb; 45(2):129-50. PubMed ID: 12604126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of runxa and runxb, zebrafish members of the runt family of transcriptional regulators.
    Burns CE; DeBlasio T; Zhou Y; Zhang J; Zon L; Nimer SD
    Exp Hematol; 2002 Dec; 30(12):1381-9. PubMed ID: 12482499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An acute myeloid leukemia gene, AML1, regulates transcriptional activation and hemopoietic myeloid cell differentiation antagonistically by two alternative spliced forms.
    Tanaka T; Tanaka K; Ogawa S; Kurokawa M; Mitani K; Yazaki Y; Shibata Y; Hirai H
    Leukemia; 1997 Apr; 11 Suppl 3():299-302. PubMed ID: 9209372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological characteristics of the leukemia-associated transcriptional factor AML1 disclosed by hematopoietic rescue of AML1-deficient embryonic stem cells by using a knock-in strategy.
    Okuda T; Takeda K; Fujita Y; Nishimura M; Yagyu S; Yoshida M; Akira S; Downing JR; Abe T
    Mol Cell Biol; 2000 Jan; 20(1):319-28. PubMed ID: 10594034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Core binding factor and its role in normal hematopoietic development.
    Speck NA
    Curr Opin Hematol; 2001 Jul; 8(4):192-6. PubMed ID: 11561154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.